Status:
COMPLETED
Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Lead Sponsor:
University Hospital, Limoges
Conditions:
Glomerulonephritis, Membranous
Neonatal Diseases and Abnormalities
Eligibility:
FEMALE
Brief Summary
Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce seve...
Eligibility Criteria
Inclusion
- Mothers having a child suffering from:
- Neonatal membranous glomerulonephritis
- Unexplained neonatal tubular defect
- Unexplained thrombotic microangiopathy
- Neonatal hemochromatosis
Exclusion
- Any cause explaining the child's disease
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00199628
Start Date
September 1 2005
End Date
August 1 2014
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Limoges University Hospital
Limoges, France, 87042